메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

The AKG and Ca-AKG of Xin Tianhe have passed the US Self-…

SHENZHEN, China, Jan. 16, 2026 -- On January 7, 2026, the AKG and Ca-AKG of Xin Tianhe Biotechnology successfully completed the Self-GRAS scientific evaluation in accordance with the US FDA GRAS standards and were approved and became the first domestic fermentation products that obtain the GRAS authoritative certification, and obtained the qualification for entering the US market, marking a crucial step to enter the global nutrition and health market. Core Breakthrough: The First Domestic Certification of Fermentation Method is Officially Implemented The alpha-ketoglutaric acid
- 김갑성 기자
- 2026-01-16 12:23
YTTEK joins Taiwan's national B5G LEO satellite program, ac…

HSINCHU, Jan. 16, 2026 -- YTTEK, a leading provider of wireless communication solutions, has been awarded a crucial contract by the Taiwan Space Agency (TASA) to develop the core communications payload for Taiwan's ambitious Beyond 5G (B5G) Low Earth Orbit (LEO) satellite initiative. Since the contract award in June 2025, the project has progressed steadily and has now entered the engineering verification phase. The contract, officially titled "Pathfinder Communication Payload Baseband Module Prototype Development," positions YTTEK at the forefront of the nation's push for sp
- 김갑성 기자
- 2026-01-16 09:41
Antengene Presents at JPM: Strong Clinical Data Update and…

SHANGHAI and HONG KONG, Jan. 16, 2026 -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, announced that it recently presented at the 44th Annual J.P. Morgan Healthcare Conference held in San Francisco. At the conference, Antengene shared the latest data and clinical development plans for its core clinical asset, ATG-022 (a CLDN18
- 김갑성 기자
- 2026-01-16 09:00
Hugel accelerates global value creation with U.S.-led growth…

- President and Global CEO Carrie Strom outlines mid-term growth strategy including global vision, U.S. channel strategy, and portfolio expansion- Hugel targets KRW900 billion in total net sales and 30% of sales from U.S. by 2028 SAN FRANCISCO, Jan. 16, 2026 -- Hugel, Inc., a leading global medical aesthetics company publicly traded in South Korea, has outlined its vision to transform from the leading Korean toxin company into a leader in global aesthetics. Having firmly established the presence of K-aesthetics in the U.S., the world's largest botulinum toxin market, the compan
- 김갑성 기자
- 2026-01-16 08:00
Kelun-Biotech Showcases Innovative Achievements and Fu…

CHENGDU, China, Jan. 16, 2026 -- From January 12 to 15, 2026, the 44th J.P. Morgan Healthcare Conference (JPMHC) was held in San Francisco, California, USA. Dr. Ge Michael, President and CEO of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK), was invited to attend the conference and delivered a keynote speech on the morning of January 15 (local time) and presented the Company's latest achievements in drug R&D, commercialization, and globalization, and outlined its innovation strategy and future development plans.&nb
- 김갑성 기자
- 2026-01-16 02:30
MOVA Life brings its smart health home vision to Silicon Valley

SAN JOSE, Calif., Jan. 16, 2026 -- Global smart technology brand MOVA hosted its 2026 global strategy and product launch event at AGI House in Silicon Valley, unveiling a new brand positioning and showcasing its expanding smart health ecosystem as part of its global growth push. At the event, MOVA Life announced its upgraded positioning as a "Smart Health Living Management Expert." For the first time in the U.S. market, the company presented an integrated portfolio spanning seven product categories, including kitchen appliances, personal care, air management, pet care
- 김갑성 기자
- 2026-01-16 00:18
GracoRoberts Acquires Sky Mart to Accelerate Latin American…

[ 메디채널 김갑성 기자 ] Transaction Enhances MRO Scale, AOG Readiness, and Lubricants Market Leadership ARLINGTON, Texas, Jan. 15, 2026 -- GracoRoberts (gracoroberts.com) today announced the acquisition of Sky Mart (skymart.aero) to advance its international footprint in Latin America, leveraging the company's corporate headquarters in Miami as a gateway to the aerospace-rich Latin American region. The acquisition significantly bolsters GracoRoberts' reach into the $6.5B Latin American MRO market, scales its AOG capability, and offers its customers access to a considerable breadth of in-stoc
- 김갑성 기자
- 2026-01-15 23:00
SECuRE trial to continue with no modifications to protocol follo…

HIGHLIGHTS Following an interim data review of the Cohort Expansion Phase (Phase II) of the SECuRE trial, the Safety Review Committee (SRC) confirms the trial will continue with no modifications to the protocol. Patient population With the SECuRE trial continuing to recruit, a total of nine participants who had evaluable data by the 25th of November 2025 were included in the interim assessment by the SRC, with the majority of participants receiving at least two cycles of 8 GBq of 67Cu-SAR-bisPSMA each by the data cut-off date. Seven participants received
- 김갑성 기자
- 2026-01-15 22:02
Recognition beyond borders: the life-long commitment of "G…

BEIJING, Jan. 15, 2026 -- A news report from China.org.cn on Gu Fangzhou, the father of sugar pills — a live oral polio vaccine: Small, sweet, and slightly gritty when dissolved on the tongue — in the childhood memory of many Chinese lies such a tiny "sugar pill." But it was never just a piece of candy. The story dates back to 1955, when a large-scale outbreak of polio (also known as infantile paralysis) swept across China. Highly contagious and debilitating, the disease mostly struck children aged seven and under. Of the 1,680 specifically reported
- 김갑성 기자
- 2026-01-15 22:00
하트스트림, 독립 응급 의료 기업으로 출범

필립스 응급의료 사업부에 속했던 하트스트림, 이머전시 케어 홀딩스의 첫 플랫폼 기업으로 출범하며, 생명을 구해온 100년의 사명 계승 보셀, 워싱턴주, 2026년 1월 15일 -- 브리지필드 캐피털(Bridgefield Capital)이 응급 의료 제품 분야의 선도기업들을 통합•성장시키기 위해 설립한 플랫폼 이머전시 케어 홀딩스(Emergency Care Holdings, 이하 'ECH')가 14일 인명 구조 응급 의료 기술 발전에 앞장설 새로운 독립 기업 하트스트림(Heartstream)의 출범을 발표했다. 하트스트림은 ECH가 로열 필립스(NYSE: PHG, AEX: PHIA)로부터 필립스 응급의료 사업부(Philips Emergency Care) 인수 절차를 완료함으로써 설립됐다. 이번 거래로 ECH는 공식 출범하게 됨과 동시에 응급 의료 분야에만 전적으로 투자하겠다는 장기 전략을 확립했다. 라이언 랜던(Ryan Landon) 하트스트림 CEO는 이렇게 말했다. "하트스트림은 심정지 생존율을 유의미하게 높이고, 응급 의료 환경에서 임상 결과를 개선하고, 의료 시스템 비용을 절감하고, 의료
- 김갑성 기자
- 2026-01-15 18:44

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2026-01-31_SAT

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 31일 13시 40분